Brightgene Bio-medical Technology Co (SHSE:688166) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688166 Brightgene Bio-medical Technology Co Ltd SHSE:688166
82 GF Score
Price ¥35.85
GF Value ¥38.59
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Brightgene Bio-medical Technology Co FFO per Share?

FFO per Share only applies to REITs.

SHSE:688166
82GF Score
Brightgene Bio-medical Technology Co Ltd SHSE:688166
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Brightgene Bio-medical Technology Co (SHSE:688166) Overvalued in 2026?

Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co stock appears to be undervalued. The current stock price of ¥35.85 is trading 7.1% below its estimated GF Value™ of ¥38.59. GuruFocus considers Brightgene Bio-medical Technology Co to be Fairly Valued.

Key valuation signals for SHSE:688166:

  • FFO per Share:
  • GF Value™: ¥38.59 vs. price of ¥35.85 (7.1% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688166 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Brightgene Bio-medical Technology Co Business Description

Address No. 218 Xinghu Street, Buildings C25-C28, Nanotechnology Park, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215123
Brightgene Bio-medical Technology Co Ltd is engaged in the Research and development and production of pharmaceutical intermediates, active pharmaceutical ingredients and formulations with high technological barriers.
82GF Score

Get the complete analysis for SHSE:688166

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥35.85
Price
¥38.59
GF Value